Effect of Papillotoxic Agents on Expression of Cyclooxygenase Isoforms in the Rat Kidney

Abstract

Inhibition of renal vasodilatory prostaglandins (PGs) and secondary ischemia due to inhibition of cyclooxygenase (COX) activity has been suggested as a possible mechanism for development of analgesic-related renal papillary necrosis (RPN) in rats. Recently, it has been shown that COX exists in two related but unique isoforms, COX-1 and COX-2. It is unclear what potential roles these isoforms play in the maintenance of blood flow in the renal papilla or genesis of RPN. We evaluated the effect of 2 papillotoxic agents, including a nonsteroidal anti-inflammatory drug, indomethacin, and a chemical agent, 2-bromoethanamine hydrobromide (2-BEA), on COX-1 and COX-2 in the renal papilla as a means of assessing what changes occur in the expression of these isoforms during the development of RPN. Female Wistar rats ≃10–17 wk old were treated with either indomethacin (75 mg/kg, single dose, or 10 mg/kg/day for 5 days) or 2-BEA (100 mg/kg/day for 4 days) to create lesions of RPN. In this study, a single 75-mg/kg dose of indomethacin did not cause light microscopic changes of RPN. However, RPN was observed in animals administered indomethacin at 10 mg/kg/day for 1 wk or 2-BEA for 5 days. The immunohistochemical analyses of kidneys showed that both COX-1 and COX-2 were present in the renal papilla of control rats. In animals treated with indomethacin (75 mg/kg), a slight to moderate decrease in both isoforms was observed in essentially normal renal papillary cells within 2 hr, that was followed by an increase in COX-2 immunoreactivity in the renal papilla, macula densa, and thick ascending limbs (both 10-and 75-mg/kg animals). This COX-2 immunoreactivity was greatest in animals with concomitant indomethacin-induced gastrointestinal injury, suggesting a possible role of inflammatory cytokines in COX-2 induction. No changes in the expression of COX isoforms in the intact papilla occurred as a result of 2-BEA; however, cells undergoing degeneration and necrosis lost immunoreactivity to both COX isoforms. The possible mechanism that leads to an initial decrease in COX immunoreactivity in indomethacin-treated animals is not known; however, a reversible ultrastructural change in the papillary cells cannot be ruled out. This decrease in COX isoforms in the renal papilla may contribute to the development of RPN through the loss of vasodilatory PGs.

Keywords

Cyclooxygenase-1 cyclooxygenase-2 prostaglandin H synthase nonsteroidal anti-inflammatory drugs kidney indomethacin 2-bromoethanamine hydrobromide

References

1. Alden CL and Frith CH (1991). Urinary system. In: Handbook of Toxicologic Pathology. WM Haschek and CG Rousseaux (eds). Academic Press, New York, 1991, pp. 347–348.

2. Arnold L , Collins C , and Starmer GA (1974). Renal and gastric lesions after phenylbutazone and indomethacin in the rat. Pathology 6: 303–313.

3. Arnold L , Collins C , and Starmer GA (1976). Further studies of the acute effects of phenylbutazone, oxyphenbutazone and indomethacin on the rat kidney. Pathology 8: 135–141.

4. Bach PH , Grasso P , Molland EA , and Bridges JW (1983). Changes in medullary glycosaminoglycan histochemistry and microvascular filling during the development of 2-bromoethanamine hydrobromide-induced renal papillary necrosis. Toxicol. Appl. Pharmacol. 69: 333–344.

5. Bach PH and Hardy TL (1985). Relevance of animal models to analgesic-associated renal papillary necrosis in humans. Kidney Int. 28: 605–613.

6. Bennett WM , Henrich WL , and Stoff JS (1996). The renal effects of non-steroidal anti-inflammatory drugs: Summary and recommendations. Am. J. Kidney Dis. 28(suppl 1): 356–362.

7. Blackshear JL , Spielman WS , Knox FG , and Romero JC (1979). Dissociation of renin release and renal vasodilation by prostaglandin synthesis inhibitors. Am. J. Physiol. 237: F20–F24.

8. Burrell JH , Yong JLC , and Macdonald GJ (1991). Irreversible damage to the medullary interstitium in experimental analgesic nephropathy in F344 rats. J. Pathol. 164: 329–338.

9. Clive DM and Stoff JS (1984). Renal syndromes associated with nonsteroidal antiinflammatory drugs. N. Engl. J. Med. 310: 563–572.

10.

10. Delmas PD (1995). Non-steroidal anti-inflammatory drugs and renal function. Br. J. Rheumatol. 34: 25–28.

11.

11. DeWitt DL and Smith WL (1988). Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc. Natl. Acad. Sci. USA 85: 1412–1416.

12.

12. DeWitt DL and Smith WL (1990). Cloning of sheep and mouse prostaglandin endoperoxide synthases. Methods Enzymol. 187: 469–479.

13.

13. DeWitt DL and Smith WL (1995). Yes, but do they still get headaches? Minireview. Cell 83: 345–348.

14.

14. Dunn MJ , Staley RS , and Harrison M (1978). Characterization of prostaglandin production in tissue culture of rat renal medullar cells. Prostaglandins 12: 37–49.

15.

15. Fletcher BS , Kujubu DA , Perrin DM , and Herschman HR (1992). Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. J. Biol. Chem. 293: 4338–4344.

16.

16. Francisco LC , Osbon JL , and Dubini GF (1982). Prostaglandins in renin release during sodium deprivation. Am. J. Physiol. 243: F537–F542.

17.

17. Funk CD , Funk LB , Kennedy ME , Pong AS , and Fitzgerald GA (1988). Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J. 5: 2304–2312.

18.

18. Greenberg SG , Lorenz JN , He XR , Schnerman JB , and Briggs JB (1983). Effect of prostaglandin synthesis inhibition on macula densa-stimulated renin secretion. Am. J. Physiol. 265: F578–F583.

19.

19. Harris RC , McKanna JA , Akai Y , Jacobson HR , Dubois RN , and Breyer MD (1994). Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J. Clin. Invest. 94: 2504–2510.

20.

20. Henry M and Tange JD (1982). The genesis and ultrastructural appearance of spontaneous renal lesion in the homozygous Gunn rat. Pathology 14: 355–361.

21.

21. Kramer SA , Meade EA , and DeWitt (1992). Prostaglandin endoperoxide synthase gene structure: Identification of the transcriptional start site and 5′-flanking regulatory sequences. Arch. Biochem. Biophys. 293: 392–400.

22.

22. Masfferer JL , Seibert K , Zwefel B , and Needleman P (1992). Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc. Natl. Acad. Sci. USA 89: 3917–3921.

23.

23. Merlie PJ , Fagan D , Mudd J , and Needleman P (1988). Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase). J. Biol. Chem. 263: 3550–3553.

24.

24. Murray MD and Brater DC (1993). Renal toxicity of the nonsteroidal anti-inflammatory drugs. Annu. Rev. Pharmacol. Toxicol. 32: 435–465.

25.

25. Powell CJ , Grasso P , Ioannides C , Wilson J , and Bridges JW (1991). Haloalkylamine-induced renal papillary necrosis: A histopathological study of structure-activity relationships. Int. J. Exp. Pathol. 72: 631–646.

26.

26. Sabatini S (1988). Analgesic-induced papillary necrosis. Semin. Nephrol. 8: 41–54.

27.

27. Seibert K , Zhang Y , Leahy K , Hauser S , Masfferer J , Perkins W , Lee L , and Isakson P (1994). Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. USA 91: 12013–12017.

28.

28. Simon LS (1994). Actions and toxic effects of the nonsteroidal antiinflammatory drugs. Curr. Opin. Rheumatol. 6: 238–251.

29.

29. Sirois J and Richards JS (1992). Purification and characterization of a novel, distinct isoform of prostaglandin endoperoxide synthase induced by human chorionic gonadotropin in granulosa cells of rat preovulatory follicles. J. Biol. Chem. 267: 6382–6388.

30.

30. Solez K , Fox JA , and Heptinstall RH (1974). Effects of indomethacin on medullary blood flow. Clin. Res. 22: 545A.

31.

31. U.S. Department of Health and Human Services (1995). Guide for the Care and Use of Laboratory Animals. Animal Resources Program, Division of Research Resources, National Institutes of Health, Bethesda, MD.

32.

32. Wheaton A and Hamilton C (1988). Non-steroidal anti-inflammatory drugs: Effects on kidney function. J. Clin. Pharmacol. 31: 588–598.

33.

33. Yokoyama C and Tanabe T (1989). Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme. Biochem. Biophys. Res. Commun. 165: 888–894.